Cite

HARVARD Citation

    Liu, Z. et al. (2023). An orthogonally activatable CRISPR-Cas13d nanoprodrug to reverse chemoresistance for enhanced chemo-photodynamic therapy. Chemical science. 14 (15), pp. 4102-4113. [Online]. 
  
Back to record